GLD-2 is a cytoplasmic poly(A) polymerase present in the Caenorhabditis elegans germ line and embryo. It is a divergent member of the DNA polymerase ␤ nucleotidyl transferase superfamily, which includes CCA-adding enzymes, DNA polymerases and eukaryotic nuclear poly(A) polymerases. The polyadenylation activity of GLD-2 is stimulated by physical interaction with an RNA binding protein, GLD-3. To test whether GLD-3 might stimulate GLD-2 by recruiting it to RNA, we tethered C. elegans GLD-2 to mRNAs in Xenopus oocytes by using MS2 coat protein. Tethered GLD-2 adds poly(A) and stimulates translation of the mRNA, demonstrating that recruitment is sufficient to stimulate polyadenylation activity. We use the same tethered assay to identify human and mouse poly(A) polymerases related to GLD-2. This may provide entrees to previously uncharacterized modes of polyadenylation in mammalian cells.
GLD-3 (35) , binds to GLD-2 and stimulates its polyadenylation activity in vitro (26) .
Based on these findings, we proposed that GLD-2 is the catalytic subunit of a heterodimeric PAP involved in cytoplasmic polyadenylation (26) . In this model, RNA-binding proteins recruit a subunit containing the PAP active site (e.g., GLD-2) to specific mRNAs. The RNA-binding proteins provide versatility in control. The enzyme, relatively inactive on its own, acquires activity by recruitment to its substrate.
Here, we test this model by tethering GLD-2 to an mRNA in vivo by using a foreign RNA-binding protein, MS2 coat protein.
Tethered GLD-2 adds poly(A) efficiently and selectively, and thereby stimulates translation of the mRNA to which it is attached. We use this tethering assay to identify human and mouse proteins that possess polyadenylation activity. These proteins are putative members of a previously undescribed family of regulatory PAPs.
mRNA reporter plasmids. pLG-MS2 (luciferase) and pJK350 (␤-galactosidase) plasmids have been described (37) . To make pLGMS2-LucHS, pLG-MS2 was cleaved with HindIII and SpeI to excise the luciferase gene fragment; ends were filled-in and religated. pLG-MS2 and pLGMS2-LucHS were linearized with BglII and transcribed with T7 RNA polymerase. pJK350 was linearized with HindIII and transcribed with SP6 RNA polymerase.
In Vitro Transcription. Plasmids were cleaved with restriction enzymes as indicated above, and transcribed with T7 or SP6 RNA polymerase. Transcriptions were performed in the presence of 6 mM m7 GpppG. In some cases, [␣- 32 P]UTP was incorporated during in vitro transcription as described (37) .
Western Blotting. Oocytes were injected with an mRNA encoding a fusion protein and collected after 6 h. Oocytes were homogenized in PBS containing a protease inhibitor mixture (Roche Diagnostics), by using 5 l of buffer per oocyte. Homogenates were centrifuged at room temperature for 10 min, and supernatants were collected. Lysate from three oocytes was loaded onto each lane of an SDS͞PAGE gel. Proteins were analyzed by Western blotting using either anti-MS2 coat protein antibody (3H4 antibody, gift of M. Kiledjian, Rutgers University, Camden, NJ) or anti-HA-tag antibody (HA11, from Covance, Princeton).
RNA Analysis. RNA extraction and poly(A) selection. Oocyte RNA was prepared by using TRI reagent, following the manufacturer's instructions (Sigma). Polyadenylated and nonpolyadenylated RNAs were separated by using the PolyATrack mRNA isolation system, following the manufacturer's instructions (Promega). RNaseH analysis. Oligo(dT)͞RNaseH treatment was performed in 200 mM KCl͞1 mM EDTA͞20 mM Tris⅐HCl, pH 8.0͞30 mM MgCl 2 ͞20 units of RNasin. A total of 0.5 g of oligo(dT) [12] [13] [14] [15] [16] [17] [18] was annealed to total RNA equivalent to two oocytes (Ϸ10 g). After addition of 3 units of RNaseH, reactions were incubated at 37°C for 90 min. Electrophoresis. After ethanol precipitation, RNAs were separated on either a denaturing formaldehyde-agarose gel (full-length mRNAs) or a 6% polyacrylamide gel (short RNAs) and analyzed by autoradiography.
Tethered Function Assays. Oocyte injections and enzyme assays were performed as described (36, 37) .
Identification of GLD-2 Relatives and Sequence Alignments. With C. elegans GLD-2 protein sequence as the query sequence (26), we ran BLASTP using the nonredundant (nr) peptide sequence database at the NCBI BLAST server (www.ncbi.nlm.nih.gov͞ blast). We aligned sequences related to GLD-2 using the SU-PERFAMILY program (http:͞͞supfam.org͞SUPERFAMILY). Based on the multiple sequence alignment, an unrooted tree was created with a phylogenetic tree program (www.ebi.ac.uk͞ clustalw) by using neighbor joining method (38) , setting on Kimura correction of distances (39) .
Results
Tethered GLD-2 Is an Efficient Poly(A) Polymerase. GLD-2 polyadenylation activity is stimulated by its interaction with a putative RNA-binding protein, GLD-3 (26) . We proposed that GLD-3 stimulates GLD-2 by recruiting it to the RNA (Fig. 1A) . If so, then bringing GLD-2 to the RNA by other means also should stimulate its activity. To test this idea, we tethered GLD-2 to a reporter mRNA by using MS2 coat protein ( Fig. 1 A, Test; ref. 40) . We used Xenopus oocytes for this purpose because they provide a robust assay for cytoplasmic polyadenylation and its effects in vivo (36, 37) .
Xenopus oocytes were first injected with an mRNA encoding a fusion of MS2 coat protein and GLD-2 (MS2͞GLD-2) or with mRNAs encoding control proteins (Fig. 1B ). After allowing 6 h for synthesis of the fusion protein, two reporter mRNAs were coinjected: a luciferase mRNA bearing MS2 binding sites in its 3Ј UTR and a ␤-galactosidase mRNA lacking MS2 sites. Luciferase and ␤-galactosidase activities were measured 16 h later.
MS2͞GLD-2 stimulates expression of the luciferase mRNA Ϸ15-fold ( Fig. 2A Upper) . Stimulation is specific, because it requires the MS2 RNA binding sites: the activity of the ␤-galactosidase reporter, which lacks binding sites, is not enhanced (Fig. 2 A Lower) . Furthermore, an MS2͞GLD-2 fusion in which the catalytic center was abolished by a point mutation (31, 34) lacked stimulatory activity [ Fig. 2 A, GLD-2(mut)]. MS2͞GLD-2 is comparable in activity to MS2͞bPAP, a fusion between MS2 and bovine nuclear PAP ( Fig. 2 A, bPAP; ref. 37). As expected, MS2͞U1A did not stimulate translation regardless of whether sites were present. The level of each MS2 fusion protein in the oocytes was similar, as assessed by Western blotting (Fig. 2B) . We conclude that GLD-2 specifically stimulates translation when bound to an mRNA in oocytes.
MS2͞GLD-2 protein catalyzed polyadenylation of the reporter to which it was tethered (Fig. 2C ). Luciferase mRNAs from oocytes containing MS2͞GLD-2 bound to biotinylated oligo(dT), whereas mRNAs from oocytes containing the active site mutant or MS2͞U1A did not. The apparent polyadenylation activity of MS2͞GLD-2 was comparable to that of MS2͞bPAP.
To examine polyadenylation in greater detail, we used short (80-nt) radiolabeled RNA substrates containing three MS2 sites. These RNAs were lengthened substantially (Ͼ300 nt) by MS2͞ GLD-2 and MS2͞bPAP, but not by MS2͞U1A or the inactive MS2͞GLD-2(mut) (Fig. 2D) . The lengthening was caused by polyadenylation, as judged by binding to biotinylated oligo(dT) (Fig. 2E ).
The Minimal Region Required for Activity. GLD-2 possesses hallmark features of the DNA polymerase ␤ (pol␤)-nucleotidyl transferase family (31) . These include three aspartic acid residues and several amino acids that bind the nucleotide contained in the catalytic and central domains (Fig. 3A) . To identify the minimum contiguous portion of GLD-2 capable of supporting polyadenylation, we prepared N-and C-terminal deletions of GLD-2, each fused to MS2 coat protein. A total of 532 amino acids could be pared from the N terminus of GLD-2, and 113 from the C terminus, without significantly reducing activity ( Fig.  3 A and B) . Further encroachments of only 30 aa at the N terminus, or 40 aa at the C terminus, caused substantial decreases in activity. Mutant proteins, including those without activity, were present at comparable levels (Fig. 3C) . We conclude that the minimum contiguous portion of GLD-2 needed for catalysis corresponds roughly to the catalytic and central domains and contains the key residues conserved among pol␤-nucleotidyl transferases.
Previously Undescribed Mouse and Human PAPs. The members of the pol␤-nucleotidyl transferase family include several different biochemical activities, including DNA polymerases, CCAadding enzymes, and 2Ј-5Ј oligo(A) synthetases, as well as canonical eukaryotic PAPs (Fig. 4A and ref. 31 ). Sequences more closely related to GLD-2 than to canonical PAPs are detected throughout eukaryotes. A subset of the most closely related sequences are depicted in a dendrogram in Fig. 4B .
The tethered function assay provides a powerful means to identify which of the GLD-2 relatives depicted in Fig. 4 are Truncated GLD-2 proteins tested. Gray boxes, catalytic domains; black boxes, central domains. ''D608'' corresponds to one of the three aspartate residues conserved in the pol␤-nucleotidyl transferase family, mutated to alanine in GLD-2(mut). (B) Translational activity. Assays were performed as in Fig. 2 A. Relative luciferase activity (ratio of luciferase to ␤-galactosidase activity) was normalized to that of GLD-2(mut). Averages and error bars are derived from four experiments (except for ⌬4, derived from two experiments). (C) Protein levels. Cell lysate equivalent to three oocytes was loaded onto each lane, and analyzed by Western blotting using anti-HA-tag antibody.
poly(A) polymerases, because neither the protein partner (the functional equivalent of GLD-3) nor the natural mRNA substrate need to be known. Thus we determined whether any of the GLD-2 relatives in the human, mouse, C. elegans, and Arabidopsis genomes were PAPs. Each of the proteins tested possesses catalytic and central domains more closely related to GLD-2 than to canonical PAPs.
We tethered all five human candidate proteins depicted in Fig.  4B by expressing them as MS2 fusion proteins in oocytes. Of these, only Hs1 was active. This protein stimulated translation (Fig. 5A ) and added poly(A) to the reporter mRNA with MS2 sites (Fig. 5C ). Its translational activity was Ϸ40% that of C. elegans GLD-2 (Fig. 5A) . Furthermore, it added poly(A) to the short RNA substrate (Fig. 5D) , as confirmed by binding to biotinylated oligo(dT) (Fig. 5E ) and treatment with RNaseH and oligo(dT) (Fig. 5F) . Similarly, one mouse protein, Mm1, that is 93% identical and 95% similar to Hs1, stimulated translation and added poly(A) (Fig. 5) . These two proteins, Hs1 and Mm1, are the most closely related to GLD-2 among the human and mouse candidate genes, and so will be referred to as hGLD-2 and mGLD-2, respectively.
Several proteins tested did not stimulate translation in the tethered function assay. These include all four other candidates from the human genome (Hs2 through Hs5). Of these, Hs3 and Hs5 were produced at levels sufficiently high to conclude they were genuinely inactive (Fig. 5B) ; full-length Hs2 and Hs4 proteins were expressed inefficiently (not shown). The closest relatives of GLD-2 in the Arabidopsis (At1) and C. elegans (Ce2) genomes also were inactive (Fig. 5A) . These proteins were produced in the oocyte at levels comparable to GLD-2 (Fig. 5B) . The simplest explanation of these data are that only some, and not all, GLD-2 relatives are poly(A) polymerases.
Discussion
Our findings demonstrate that GLD-2 gains activity by recruitment to an mRNA substrate. Tethering GLD-2 to an mRNA results in polyadenylation and stimulation of translation. The stimulation of translation is due to poly(A) addition, because a point mutation that eliminates GLD-2's polyadenylation activity also eliminates the enhancement. These data support the model that RNA binding partners of GLD-2 bring the protein to the 3Ј end of mRNAs, providing sequence specificity (26) .
Many enzymes that polymerize nucleotides into nucleic acid gain sequence specificity by interaction with distinct protein partners. Most replication and transcription enzymes follow this principle. In nuclear polyadenylation, a PAP is brought to the pre-mRNA through interactions with a multisubunit RNAbinding protein, called cleavage and polyadenylation specificity factor in mammalian cells (CPSF; refs. [17] [18] [19] . Cytoplasmic   Fig. 4 . GLD-2-related sequences and candidate PAPs. (A) pol␤-nucleotidyl transferase family. The family includes not only GLD-2 (and the DNA polymerases, Trf4p and Trf5p, of Saccharomyces cerevisiae), but also CCA-adding enzymes (CCA), 2Ј-5Јoligo(A) synthetases (2Ј-5ЈA), terminal transferase (TdT), the polX polymerases, and enzymes that transfer nucleotidyl groups to other nonnucleic acid compounds. The image is based on Aravind and Koonin (31) . (B) Cladogram of a subset of sequences most similar to GLD-2, emphasizing those relevant for this work. Sequences tested for PAP activity are in boxes. Black boxes, proteins that possessed PAP activity as tethered proteins; white boxes with an ''X,'' proteins without activity as tethered proteins (although the proteins were expressed); gray boxes, sequences shown in other work to be cytoplasmic PAPs (27, 28) . Hs2 and Hs4 proteins were expressed at too low levels to be assessed confidently. ''bPAP'' indicates the canonical nuclear PAP derived from Bos taurus: the other canonical PAPs are very closely related. (C) Structure of the GLD-2 relatives tested. Gray boxes, catalytic domains; black boxes, central domains; RRM, the RRM-like region present in canonical nuclear PAPs; white boxes, other regions. Hs2 also has a retrovirus zinc-finger-like domain.
polyadenylation in Xenopus oocytes requires a distinct cytoplasmic form of CPSF (37, 41, 42 ). An additional protein, CPEB, binds both the RNA and CPSF (37, 41, 42) , and hence helps to recruit the PAP. C. elegans GLD-3 binds to GLD-2 and stimulates its polyadenylation activity in vitro (26, 35) . RNA-binding proteins, perhaps including CPEB, cytoplasmic CPSF, and GLD-3-related proteins, may enhance the activity of GLD-2 family members.
GLD-2 and its human and mouse homologues, hGLD-2 and mGLD-2, share sequence similarities that distinguish them from other eukaryotic PAPs. All PAPs, including GLD-2, possess a collection of catalytic and nucleotide-binding residues. GLD-2 family members are very closely related to one another, as are the nuclear PAPs to one another. GLD-2 family members possess insertions and deletions relative to the nuclear PAP family, and these might underlie differences in their properties. For example, canonical mammalian PAPs possess two bipartite nuclear localization signals on either side of a S͞T-rich domain at their C termini (33) ; by sequence inspection, GLD-2, mGLD-2, and hGLD-2 do not possess a region related to this C-terminal segment. S. pombe Cid1p and Cid13p, like C. elegans GLD-2, are cytoplasmic poly(A) polymerases (27, 28) , yet are more distantly related to the GLD-2 homologues than are Ce2 and Hs3, both of which are inactive in the tethered function assay (Fig. 4 and 5) . Thus, further tests are needed to determine which features are critical for PAP activity and biological functions in vivo.
Three other PAP genes, in addition to the one encoding the canonical nuclear PAP, have been identified in mammalian cells. The TPAP gene is expressed in the mouse testes. Its protein product is cytoplasmic and adds poly(A) to a subset of mRNAs in that tissue (43, 44) . A second gene, neoPAP, is expressed at elevated levels in human neoplasms (45) . A third gene encodes PAP␥, a protein very similar in enzymatic activity to the canonical PAP. Indeed, PAP␥ polyadenylates RNAs in an AAUAAA-dependent manner in the presence of CPSF (46) . TPAP, neoPAP, and PAP␥ are all much more closely related in sequence to the canonical nuclear PAP than are hGLD-2 and mGLD-2. For example, the human canonical PAP (PAPII) is 71% similar in sequence overall to neoPAP (45) , but only 23% similar to hGLD-2. Furthermore, hGLD-2 possesses an Nterminal segment lacking in canonical PAPs, and lacks similarity to the C-terminal region of other PAPs.
The diversity of poly(A) polymerases in mammalian cells is striking. Five genes encode identified PAP proteins: the canonical PAPs, neo-PAP (45), TPAP (43, 44, 47) , PAP␥ (46) , and the GLD-2 homologues reported here. Alternative processing of lane and analyzed by Western blotting using anti-HA antibody. Shown on the left are positions of protein markers used to calibrate molecular mass. (C) Poly(A) status of reporter mRNAs. 32 P-labeled luciferase mRNA was injected into oocytes expressing the indicated fusion proteins. RNA was extracted from oocytes after 16 h and fractionated by using biotinylated oligo(dT). Ϫ, RNAs that did not bind the resin; ϩ, RNAs that bound the resin. (D) Polyadenylation of short RNA substrates. A 32 P-labeled RNA containing three MS2 sites was injected into oocytes expressing the MS2 fusion proteins indicated above each lane. RNA was extracted after 16 h and analyzed by electrophoresis. Shown on the left are positions of RNAs with various lengths of poly(A) (determined by comparison to markers). (E) Oligo(dT) retention. RNAs containing three MS2 sites were injected into oocytes expressing the indicated fusion proteins. Extracted RNAs were fractionated by using biotinylated oligo(dT). Ϫ, RNAs that did not bind the resin; ϩ, RNAs that bound the resin. Left, positions of RNAs with various lengths of poly(A) (determined by comparison to markers). Input, RNA before injection. (F) Oligo(dT)͞RNaseH. RNAs containing three MS2 sites were injected into oocytes expressing the indicated fusion proteins. Extracted RNAs were incubated with oligo(dT) and RNaseH. Ϫ, no RNaseH; ϩ, RNaseH added. Arrowheads indicate positions of the injected RNA and of the same RNA with a 300-nt tail. Input, RNA before injection.
Fig. 5.
Identification of poly(A) polymerases. (A) Translational activity. Assays were performed as in Fig. 2 A. Relative luciferase activity (ratio of luciferase to ␤-galactosidase activity) was normalized to that of GLD-2(mut). (B) Protein levels. Cell lysate equivalent to three oocytes was loaded onto each transcripts of the canonical PAP generates additional diversity (48) , as does their regulated phosphorylation (49) (50) (51) . The diversity of poly(A)-adding enzymes suggests an even greater degree of control over poly(A) length than already has been revealed.
The discovery of mouse and human GLD-2 homologues may provide an entree into previously undescribed biological roles of polyadenylation in mammalian cells. In C. elegans, gld-2 regulates stem cell fates and is required for stem cells to complete meiosis (30) . Furthermore, gld-2 is required redundantly with gld-1 for stem cell differentiation: gld-1 gld-2 double mutants do not differentiate into gametes, but instead form germ line tumors (30) . In S. pombe, CID1 and CID13 monitor DNA damage and nucleotide levels, thereby controlling the cell cycle (27, 28) . Perhaps, as with GLD-2, Cid1p, and Cid13p, the mammalian proteins will participate in mitotic controls in certain cell types. Transcripts of mGLD-2 and hGLD-2 appear to be present in a broad range of tissues and cell types (e.g., http:͞͞source.stanford.edu͞cgi-bin͞source͞sourceSearch). Thus, the roles of these enzymes, and perhaps of regulated changes in poly(A) length, may now become accessible in mammalian somatic cells.
